Mutations and epimutations to GRIN2B have been associated with risk for neurological diseases including attention-deficit/hyperactivity disorder, autism spectrum disorders, and schizophrenia [92–94]. Here, GRIN2B is linked to attention deficit-hyperactivity disorder.